Evidence map›Paper›PMID 30781721›Full record

Observational studyCells2019

The Role of Osteopontin as a Diagnostic and Prognostic Biomarker in Sepsis and Septic Shock.

Luigi Mario Castello, Marco Baldrighi, Luca Molinari, Livia Salmi, Vincenzo Cantaluppi, Rosanna Vaschetto, Greta Zunino, Marco Quaglia, Mattia Bellan, Francesco Gavelli and 3 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Placental Molecular Expression of Different Pathogenic Vaginal Infections.International journal of molecular sciences · 2025
    Article
  6. The injury effect of osteopontin in sepsis-associated lung injury.Journal of inflammation (London, England) · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Luigi Mario CastelloDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. luigi.castello@med.uniupo.it.
Marco BaldrighiDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. marco.baldrighi590@gmail.com.
Luca MolinariDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. luca.molinari@med.uniupo.it.
Livia SalmiDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. livia.salmi@uniupo.it.
Vincenzo CantaluppiDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. vincenzo.cantaluppi@med.uniupo.it.
Rosanna VaschettoDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. rosanna.vaschetto@med.uniupo.it.
Greta ZuninoDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. greta.fda@gmail.com.
Marco QuagliaDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. marco.quaglia@med.uniupo.it.
Mattia BellanDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. bellanmattia@yahoo.it.
Francesco GavelliDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. gavelli.francesco@gmail.com.
Paolo NavalesiDivision of Anesthesiology and Reanimation, Department of Medical and Surgical Sciences, Università degli Studi Magna Grecia, 88100 Catanzaro (CZ), Calabria, Italy. pnavalesi@gmail.com.
Gian Carlo AvanziDepartment of Translational Medicine, Università degli Studi del Piemonte Orientale, Via Solaroli 17, 28100 Novara (NO), Piedmont, Italy. giancarlo.avanzi@med.uniupo.it.
Annalisa ChiocchettiCAAD, IRCAD, Department of Health Sciences, Università degli Studi del Piemonte Orientale, Corso Trieste 15, 28100 Novara (NO), Piedmont, Italy. annalisa.chiocchetti@med.uniupo.it.
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITMagna Graecia University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host-response to infections. Osteopontin (OPN) is an extracellular matrix protein involved in the inflammatory response. Our aim was to evaluate the diagnostic and prognostic performance in sepsis of a single OPN determination in the Emergency Department (ED). We conducted a single-centre prospective observational study in an Italian ED where we enrolled 102 consecutive patients presenting with suspected infection and qSOFA ≥ 2. OPN plasma concentration was found to be an independent predictor of sepsis (OR = 1.020, 95% CI 1.002⁻1.039,

Indexed as

AgedAged, 80 and overArea Under CurveBiomarkersFemaleHumansLogistic ModelsMaleOsteopontinPrognosisROC CurveShock, SepticBiomarkersOsteopontinbiomarkersdiagnosisEmergency DepartmentOsteopontinprognosisrisk stratificationsepsis

Identifiers

PMID30781721
PMCPMC6407102
OpenAlexW2913144344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.